🔎 Trials Near Me

Beranda › Kanker Paru › Arizona › Gilbert

Uji klinis Kanker Paru di Gilbert, AZ

8 studi untuk Kanker Paru mencari peserta di lokasi sekitar Gilbert (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Ironwood Cancer & Research Centers, Gilbert
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07222566

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

Menerima pesertaFase 1/2
  • Banner Health- MD Anderson Cancer Center, Gilbert
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT05786924

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Menerima pesertaFase 3
  • Banner MD Anderson Cancer Center, Gilbert
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 8 Sep 2026 · NCT06119581

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Menerima pesertaFase 1/2
  • Avenzo Therapeutics Recruiting Site, Gilbert
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT07038343

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Menerima pesertaFase 1/2
  • Banner MD Anderson Cancer Center, Gilbert
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Jun 2026 · NCT06162221

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

Menerima pesertaFase 2
  • Banner Health MD Anderson, Gilbert
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT04614103

A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression

Menerima pesertaFase 1/2
  • Banner Health, Gilbert
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT06051695

A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Menerima pesertaFase 1/2
  • Banner MD Anderson Cancer Center, Gilbert
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2025 · NCT06682793

Uji klinis Kanker Paru di kota lain

Studi lain di Gilbert

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.